Global Uveitis Treatment Market Trends and Forecast to 2025
Uveitis Treatment Market – Insights
Uveitis refers to inflammation caused in the uvea of the eye. A uvea is the middle layer of the eye that consists of three components namely iris, cilliary body, and the choroid. Uveitis is caused by various factors such as inflammatory diseases, injuries in the eye, microbial infections such as viral, bacterial, and fungal infection or exposure to certain toxic chemicals such as strong acids or pesticides. However, in many cases the cause of this condition remains unknown. It is also found to be effecting people belonging to the age group of 20–50 years. The condition is classified based on the location of inflammation in the uvea and is categorized in three types including anterior uveitis that causes inflammation in the iris and is the most commonly encountered type. The other two types include intermediate uveitis and posterior uveitis that affects the posterior choroid part of the uvea. Uveitis can be treated with the help of various drugs that include corticosteroids, immunosuppressant, monoclonal antibodies, analgesics, and drug formulations.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1094
Rise in development of innovative biologics is expected to accelerate growth of the market
Primary driving factor contributing towards growth of the uveitis treatment market is rising incidence of uveitis. According to a study by American University of Beirut Medical Center in 2015, Uveitis is responsible for 10% of legal blindness in the U.S. and up to 25% of blindness in the developing countries. Moreover, according to a study conducted by F. I. Proctor Foundation, University of California, San Francisco in 2013 suggested that uveitis incidence rate among the U.S. population could be approximated to 24.9 cases per 100,000 people. In addition to this, several other factors driving growth of the market include rise in healthcare expenditure for treatment development and development of new and innovative biologics for uveitis treatment. However, factors limiting growth of the market include side effects such as kidney damage, high blood sugar, and osteoporosis due to immunosuppressant drugs. Moreover, complications associated with the medication could result in irreversible blindness, which is a major factor limiting the market growth.
The global uveitis treatment market was valued at US$ 555.51 Mn in 2016 and is expected to exhibit a robust CAGR of 6.0% over the forecast period (2017–2025).
Speedy FDA approvals for uveitis treatment drugs to propel the market growth
A large number of new as well as established companies are focusing on development of drugs for the treatment of uveitis in various forms such as monoclonal antibodies, immunosuppressant, corticosteroids, anti-fungal agents, anti-viral agents, and others. FDA is focusing on speedy drug approval process as uveitis has serious ill effects leading to disorders such as glaucoma and permanent blindness. This creates a highly conducive environment for market players to invest in research and development activities to file for patents as well as develop generic biologics for treating this disorder. According to the Regulatory Affairs Professionals Society, FDA has approved around 38 generic drugs till July 2017.
Asia Pacific is expected to witness a significant growth in the global uveitis treatment market and this can be attributed to increasing number of regional players focusing on development of biologics for the treatment of uveitis. For instance, Santen Pharmaceuticals received U.S. FDA approval for its new drug in April 2017, for the treatment of non-infectious uveitis of the posterior segment.
Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/1094
Some of the major players operating in the uveitis treatment market are AbbVie, Inc., Novartis AG, Eyegate Pharmaceuticals, Inc., Santen Pharmaceuticals, Allergan Plc, Regeneron Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., and Alimera Sciences.
You may be interested
Plastisols Market Applications, Types and Market Analysis to 2026Alex Mathew - August 14, 2018
Plastisols Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation,…
Phytonutrients Market Revenue Growth Predicted by 2025Mohit Joshi - August 14, 2018
Phytonutrients Market report provides the statistical analysis of “Phytonutrients Market: Global Industry Analysis, Size, Share, Growth, Trends, Outlook and Forecasts” present in the industry space. The report helps…
Citric Acid Market Headed for Growth and Global Expansion by 2026Mohit Joshi - August 14, 2018
Citric Acid Market report provides the statistical analysis of “Citric Acid Market: Global Industry Analysis, Size, Share, Growth, Trends, Outlook and Forecasts” present in the industry space. The…